Search for Clinical Trial Results

Sponsored By

Leishmaniasis, Cutaneous - 25 Studies Found

Status Study
Completed Study Name: Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Condition: Leishmaniasis, Cutaneous
Date: 2007-05-29
Interventions:
  • Drug: meglumine antimoniate, allopurinol

Available Study Name: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Date: 2012-06-18
Interventions: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days
Completed Study Name: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Date: 2005-05-23
Interventions: Biological: Leish-111f + MPL-SE vaccine
Terminated Study Name: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Date: 2010-06-07
Interventions: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f
Completed Study Name: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)
Condition: Leishmaniasis, Cutaneous
Date: 2009-12-14
Interventions:
  • Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)

Completed Study Name: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama
Condition: Leishmaniasis, Cutaneous
Date: 2010-03-08
Interventions:
  • Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)

Completed Study Name: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
Condition: Cutaneous Leishmaniasis
Date: 2008-06-20
Interventions:
  • Drug: WR 279,396 A topical cre
Completed Study Name: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Date: 2010-01-13
Interventions:
  • Drug: Liposomal meglumine antimoniate (Glucantime)

Completed Study Name: Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
Condition: Cutaneous Leishmaniasis
Date: 2008-01-21
Interventions:
  • Drug: WR 279,396 topical cream

Completed Study Name: Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Date: 2009-02-08
Interventions:
  • Procedure: Photodynamic therapy

Next >>>